Deletion of the first exon of calmodulin-lysine N-methyltransferase (CaM KMT, previously C2orf34) has been reported in two multigene deletion syndromes, but additional studies on the gene have not been reported. Here we show that in the cells from 2p21 deletion patients the loss of CaM KMT expression results in accumulation of hypomethylated calmodulin compared to normal controls, suggesting that CaM KMT is essential for calmodulin methylation and there are no compensatory mechanisms for CaM methylation in humans. We have further studied the expression of this gene at the transcript and protein levels. We have identified 2 additional transcripts in cells of the 2p21 deletion syndrome patients that start from alternative exons positioned outside the deletion region. One of them starts in the 2nd known exon, the other in a novel exon. The transcript starting from the novel exon was also identified in a variety of tissues from normal individuals. These new transcripts are not expected to produce proteins. Immunofluorescent localization of tagged CaM KMT in HeLa cells indicates that it is present in both the cytoplasm and nucleus of cells whereas the short isoform is localized to the Golgi apparatus. Using Western blot analysis we show that the CaM KMT protein is broadly expressed in mouse tissues. Finally we demonstrate that the CaM KMT interacts with the middle portion of the Hsp90 molecular chaperon and is probably a client protein since it is degraded upon treatment of cells with the Hsp90 inhibitor geldanamycin. These findings suggest that the CaM KMT is the major, possibly the single, methyltransferase of calmodulin in human cells with a wide tissue distribution and is a novel Hsp90 client protein. Thus our data provides basic information for a gene potentially contributing to the patient phenotype of two contiguous gene deletion syndromes.
References
[1]
Parvari R, Brodyansky I, Elpeleg O, Moses S, Landau D, et al. (2001) A recessive contiguous gene deletion of chromosome 2p16 associated with cystinuria and a mitochondrial disease. Am J Hum Genet 69: 869–875.
[2]
Parvari R, Gonen Y, Alshafee I, Buriakovsky S, Regev K, et al. (2005) The 2p21 deletion syndrome: Characterization of the transcription content. Genomics 86: 195–211.
[3]
Parvari R, Hershkovitz E (2007) Chromosomal microdeletions and genes’ functions: A cluster of chromosomal microdeletions and the deleted genes’ functions. Eur J Hum Genet 15: 997–998.
[4]
Chabrol B, Martens K, Meulemans S, Cano A, Jaeken J, et al. (2008) Deletion of C2orf34, PREPL and SLC3A1 causes atypical hypotonia–cystinuria syndrome. J Med Genet 45: 314–318.
[5]
Magnani R, Dirk LMA, Trievel RC, Houtz RL (2010) Calmodulin methyltransferase is an evolutionarily conserved enzyme that trimethylates lys-115 in calmodulin. Nat Commun 1: 1–6.
[6]
Faas GC, Raghavachari S, Lisman JE, Mody I (2011) Calmodulin as a direct detector of Ca2 signals. Nat Neurosci 14: 301–304.
[7]
Pearl LH, Prodromou C (2006) Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem 75: 271–294.
[8]
Vaughan CK, Neckers L, Piper PW (2010) Understanding of the Hsp90 molecular chaperone reaches new heights. Nat Struct Mol Biol 17: 1400–1404.
[9]
Zhang MH, Lee JS, Kim HJ, Jin DI, Kim JI, et al. (2006) HSP90 protects apoptotic cleavage of vimentin in geldanamycin-induced apoptosis. Mol Cell Biochem 281: 111–121.
[10]
Bar-Peled M, Raikhel N (1996) A method for isolation and purification of specific antibodies to a protein fused to the GST. Anal Biochem 241: 140–142.
[11]
Sutherland BW, Toews J, Kast J (2008) Utility of formaldehyde cross-linking and mass spectrometry in the study of protein–protein interactions. J Mass Spectrom 43: 699–715.
[12]
Kozak M (1996) Interpreting cDNA sequences: Some insights from studies on translation. Mamm Genome 7: 563–574.
[13]
Oh SH, Roberts DM (1990) Analysis of the state of posttranslational calmodulin methylation in developing pea plants. Plant Physiol 93: 880–887.
[14]
Rowe P, Wright L, Siegel F (1986) Calmodulin N-methyltransferase. Partial purification and characterization. J Biol Chem 261: 7060–7069.
[15]
Takemori N, Komori N, Thompson JN, Yamamoto MT, Matsumoto H (2007) Novel eye-specific calmodulin methylation characterized by protein mapping in drosophila melanogaster. Proteomics 7: 2651–2658.
[16]
Gopalakrishna R, Anderson WB (1982) Ca2 -induced hydrophobic site on calmodulin: Application for purification of calmodulin by phenyl-sepharose affinity chromatography. Biochem Biophys Res Commun 104: 830–836.
[17]
Taherian A, Krone PH, Ovsenek N (2008) A comparison of Hsp90α and Hsp90β interactions with cochaperones and substrates. Biochem Cell Biol 86: 37–45.
[18]
Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, et al. (1997) Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent. Cell 89: 239–250.
Catlett MG, Kaplan KB (2006) Sgt1p is a unique co-chaperone that acts as a client adaptor to link Hsp90 to Skp1p. J Biol Chem 281: 33739–33748.
[21]
Hawle P, Siepmann M, Harst A, Siderius M, Reusch HP, et al. (2006) The middle domain of Hsp90 acts as a discriminator between different types of client proteins. Mol Cell Biol 26: 8385–8395.
[22]
Sato S, Fujita N, Tsuruo T (2000) Modulation of akt kinase activity by binding to Hsp90. Proc Natl Acad Sci USA 97: 10832–10837.
[23]
Shames DS, Minna JD (2008) IP6K2 is a client for HSP90 and a target for cancer therapeutics development. Proc Natl Acad Sci USA 105: 1389–1390.
[24]
Whitesell L, Lindquist SL (2005) HSP90 and the chaperoning of cancer. Nat Rev Cancer 5: 761–772.
[25]
Sharp S, Workman P (2006) Inhibitors of the HSP90 molecular chaperone: Current status. Adv Cancer Res 95: 323–348.
Jenuwein T, Allis CD (2001) Translating the histone code. Science 293: 1074–1080.
[28]
Panina S, Stepan A, la Cour JM, Jacobsen K, Kallerup LK, et al. (2012) Significance of calcium binding, tyrosine phosphorylation, and lysine trimethylation for the essential function of calmodulin in vertebrate cells analyzed in a novel gene replacement system. J Biol Chem 287: 18173–18181.
[29]
Oh SH, Steyner HY, Dougall DK, Roberts DM (1992) Modulation of calmodulin levels, calmodulin methylation, and calmodulin binding proteins during carrot cell growth and embryogenesis. Arch Biochem Biophys 297: 28–34.
[30]
Roberts DM, Rowe PM, Siegel FL, Lukas TJ, Watterson DM (1986) Trimethyllysine and protein function. Effect of methylation and mutagenesis of lysine 115 of calmodulin on NAD kinase activation. J Biol Chem 261: 1491–4.
[31]
Molla A, Kilhoffer MC, Ferraz C, Audemard E, Walsh MP, et al. (1981) Octopus calmodulin. The trimethyllysyl residue is not required for myosin light chain kinase activation. J Biol Chem 256: 15–8.
[32]
Szilak L, Finta C, Patthy A, Venetianer P, Kiss A (1994) Self-methylation of BspRI DNA-methyltransferase. Nucleic Acids Res 22: 2876.
[33]
Williamson EA, Rasila KK, Corwin LK, Wray J, Beck BD, et al. (2008) The SET and transposase domain protein metnase enhances chromosome decatenation: Regulation by automethylation. Nucleic Acids Res 36: 5822.
[34]
Sampath SC, Marazzi I, Yap KL, Sampath SC, Krutchinsky AN, et al. (2007) Methylation of a histone mimic within the histone methyltransferase G9a regulates protein complex assembly. Mol Cell 27: 596–608.
[35]
Chin HG, Esteve PO, Pradhan M, Benner J, Patnaik D, et al. (2007) Automethylation of G9a and its implication in wider substrate specificity and HP1 binding. Nucleic Acids Res 35: 7313–7323.
[36]
Siddique AN, Jurkowska RZ, Jurkowski TP, Jeltsch A (2011) Auto-methylation of the mouse DNA-(cytosine C5)-methyltransferase Dnmt3a at its active site cysteine residue. FEBS J 278: 2055–2063.
[37]
Barreda EG, Avila J (2011) Tau regulates the subcellular localization of calmodulin. Biochem Biophys Res Commun 408: 500–504.
[38]
Hoeflich KP, Ikura M (2002) Calmodulin in action: Diversity in target recognition and activation mechanisms. Cell 108(6): 739–742.
[39]
Lai D, Wan M, Wu J, Preston-Hurlburt P, Kushwaha R, et al. (2009) Induction of TLR4-target genes entails calcium/calmodulin-dependent regulation of chromatin remodeling. Proc Natl Acad Sci 106: 1169.
[40]
Sugiana C, Pagliarini DJ, McKenzie M, Kirby DM, Salemi R, et al. (2008) Mutation of C20orf7 disrupts complex I assembly and causes lethal neonatal mitochondrial disease. Am J Hum Genet 83: 468–478.
[41]
Hamamoto R, Furukawa Y, Morita M, Iimura Y, Silva FP, et al. (2004) SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat Cell Biol 6: 731–740.
